- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03176615
Meal-induced Thrombin Generation Before and After Gastric Bypass
November 30, 2021 updated by: Line Espenhain Landgrebe, Hospital of South West Jutland
Meal-induced Thrombin Generation in Obese Women and Men Before and After Gastric Bypass - a Model of Intentional Weight Loss
The purpose of this study is to investigate harmful effects of intentional weight loss.
Intentional weight loss has been linked to increased risk of cardiovascular disease in overweight individuals, but the link between intentional weight loss and thrombotic disease is poorly understood.
Postprandial coagulation activation, including thrombin generation, is a potential mechanism after high-fat meals.
Thirty obese patients admitted to gastric bypass will be included in a randomized, cross-over clinical trial.
All patients will consume a high-fat meal and a low-fat meal served in a randomized order on two study days (two to seven days apart).
This cross-over study will be carried out before weight loss, during lifestyle-induced weight loss, and during weight loss 3-4 months after gastric bypass.
Fasting and postprandial blood samples are collected on each study days, while one fecal sample is collected for each study period.
The study will contribute to our understanding of mechanisms underlying harmful effects of weight loss, and future, dietary guidelines in relation to intentional weight loss programs must be modified.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Esbjerg, Denmark, 6700
- Center of Bariatric Research, Dep. of Endocrinology, Hospital of South West Jutland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligible for gastric bypass surgery
Exclusion Criteria:
- Use of anticoagulants, platelet inhibitors and oral contraceptives
- Known liver diseases, any malignant disorders, or known coagulation diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A (Cross-over Group 1)
Subjects randomly assigned to two experimental diets.
This arm will receive high-fat meals first, followed by a washout period of two-seven days and then low-fat meals.
|
The intervention will run concurrently with the gastric bypass treatment at the hospital.
The first intervention is carried out before weight loss, and the intervention is repeated two times concurrently with two periods of weight loss (lifestyle and gastric bypass)
|
Experimental: Group B (Cross-over Group 2)
Subjects randomly assigned to two experimental diets.
This arm will receive low-fat meals first, followed by a washout period of two-seven days and then high-fat meals.
|
The intervention will run concurrently with the gastric bypass treatment at the hospital.
The first intervention is carried out before weight loss, and the intervention is repeated two times concurrently with two periods of weight loss (lifestyle and gastric bypass)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial peak mean of prothrombin fragment 1+2 concentrations
Time Frame: Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Blood samples are collected after high-fat and low-fat meals on two study days.
|
Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial peak mean of cardiovascular risk markers concentrations
Time Frame: Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Blood samples are collected after high-fat and low-fat meals on two study days.
|
Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Laboratory tests of fecal samples
Time Frame: Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Bacterial components of fecal samples
|
Measures before weight loss, change from baseline to after lifestyle-induced weight loss and 4 months post-surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Else Bladbjerg, M.Sc. PhD, Unit for Thrombosis Research, Department of Regional Health Research, Hospital of South West Jutland and University of Southern Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
February 1, 2021
Study Completion (Actual)
November 30, 2021
Study Registration Dates
First Submitted
May 29, 2017
First Submitted That Met QC Criteria
June 2, 2017
First Posted (Actual)
June 5, 2017
Study Record Updates
Last Update Posted (Actual)
December 1, 2021
Last Update Submitted That Met QC Criteria
November 30, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HospitalSWJ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Medical University of ViennaCompleted
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Suspended
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Experimental diet
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
University of LausanneUniversity of LiegeCompletedHereditary Fructose IntoleranceBelgium
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...CompletedCardiovascular DiseasesCanada
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Recruiting
-
Chonbuk National University HospitalCompletedFunctional ConstipationKorea, Republic of
-
Universitätsmedizin MannheimCompletedQuality of LifeGermany
-
Milton S. Hershey Medical CenterStanley Medical Research InstituteCompleted
-
Rhode Island HospitalEnrolling by invitationGastrointestinal Diseases | Colitis | Pediatric Disorder | Pediatric Crohns Disease | Procedural SequelaeUnited States
-
Société des Produits Nestlé (SPN)CompletedToddlers Bone MetabolismPhilippines
-
University of Wisconsin, MadisonCompletedNon-alcoholic Fatty Liver DiseaseUnited States